GlassScriptPhysician profile
Cecilia H Tran
NPI 1578523031
$1,728.45
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $306 · 2021: $308 · 2022: $320 · 2023: $182 · 2024: $19.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $202.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $402.59 | 2019-2023 | Xarelto |
| Astellas Pharma US INC | $356.29 | 2019-2021 | |
| Amgen INC. | $101.58 | 2019-2023 | Repatha, Otezla |
| Boston Scientific Corporation | $89.90 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $83.14 | 2019 | |
| Abbvie INC. | $78.44 | 2019-2022 | |
| Novo Nordisk INC | $68.44 | 2021-2022 | |
| Glaxosmithkline, LLC. | $62.80 | 2019-2024 | Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $60.21 | 2019-2022 | |
| Pfizer INC. | $50.21 | 2020-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.60 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $38.30 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.02 | 2019-2021 | |
| Biogen, INC. | $30.97 | 2020 | |
| Allergan, INC. | $28.72 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $24.37 | 2023 | Crysvita |
| Ibsa Pharma INC. | $23.77 | 2022 | |
| Sanofi Pasteur INC. | $22.98 | 2023 | |
| Shield Therapeutics INC | $21.39 | 2023 | Accrufer |
| Gilead Sciences, INC. | $20.50 | 2021 | |
| Alnylam Pharmaceuticals INC. | $18.37 | 2022 | |
| Amarin Pharma, INC. | $17.02 | 2019 | |
| Edwards Lifesciences Corporation | $16.81 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $14.74 | 2021 | |
| Optos, INC. | $14.31 | 2021 | |
| Bardy Diagnostics, INC. | $9.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cecilia Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.